ArticleHearing research2025
Supporting cell involvement in cochlear damage and repair: Novel insights from a quantitative analysis of cyclodextrin-induced ototoxicity in mice.
Article in Hearing research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The aryl hydrocarbon receptor is expressed in non-sensory cells in the cochlea and regulates hair cell survival.Frontiers in molecular neuroscience · 2026Article
- Organ of Corti macrophages: a distinct group of cochlear macrophages with potential roles in supporting cell degeneration and survival.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The cochlea is vulnerable to various pathological conditions, with sensory cells typically being the primary targets of damage. However, supporting cells also experience significant impacts. Despite their critical role in maintaining the structural and functional integrity of the sensory epithelium, the supporting cell involvement in cochlear damage remains poorly understood. This study aimed to elucidate the susceptibility of supporting cells in cochlear damage and their role in structural repair, using a mouse model of ototoxicity induced by cyclodextrin-a cyclic oligomer of glucose that is known to preferentially damage outer hair cells at high doses. A morphological examination of the cochlea showed that cyclodextrin exposure caused significant sensory cell loss, particularly affecting outer hair cells across the cochlear spiral, except at the apex. Despite extensive hair cell damage, most supporting cells in the apical and middle cochlear regions survived. In the basal end, where substantial supporting cell loss occurred, certain Deiters' cells survived even after losing their phalangeal processes. Additionally, our observations indicate that Hensen's cells contribute to forming an epithelial layer over the basilar membrane when the organ of Corti collapses. Further quantitative analysis revealed location-dependent susceptibility among supporting cell types. Deiters' cells demonstrated greater resilience than pillar cells. Notably, the three rows of Deiters' cells displayed differential susceptibility: the third row showed a more significant loss in regions with sporadic Deiters' cell loss, while the first row exhibited an increased loss in areas adjacent to regions of complete Deiters' cell depletion. The reduction of Hensen's cells started in the middle section of the cochlea, occurring at a greater level than the reduction observed in Deiters' and pillar cells. However, in the extreme base, where both pillar and Deiters' cells were largely or completely absent, some Hensen's cells were still present. Together, these findings provide new insights into the varying vulnerability of supporting cells to cochlear damage and underscore their essential role in structural repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.